Corient Private Wealth
BNTX icon

Corient Private Wealth’s BioNTech BNTX Stock Holding History

Corient Private Wealth’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,784
Closed -$203K – 2307
2024
Q4 		$203K Sell
1,784
-150
-8% -$17.1K ﹤0.01% 2106
2024
Q3 		$230K Buy
+1,934
New +$178K ﹤0.01% 2157
2024
Q2 		– Sell
-2,304
Closed -$213K – 2325
2024
Q1 		$213K Sell
2,304
-175
-7% -$16.8K ﹤0.01% 2071
2023
Q4 		$262K Sell
2,479
-707
-22% -$71.2K ﹤0.01% 1936
2023
Q3 		$346K Buy
+3,186
New +$352K ﹤0.01% 1683
2023
Q2 		– Sell
-1,867
Closed -$233K – 2082
2023
Q1 		$233K Buy
1,867
+257
+16% +$35.3K ﹤0.01% 1726
2022
Q4 		$242K Buy
+1,610
New +$248K ﹤0.01% 1415

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Corient Private Wealth's BNTX Position: Q1 2025 in Review

Corient Private Wealth sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 1,784 shares — an estimated $203K sold.

Corient Private Wealth first reported a position in BNTX in Q4 2022 and held it in 7 quarters. The position peaked at $346K in Q3 2023. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Corient Private Wealth reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Corient Private Wealth sold 1,784 BioNTech shares in Q1 2025, an estimated $203K.
  • Corient Private Wealth first reported a position in BioNTech in Q4 2022 and held it in 7 quarters.
  • Corient Private Wealth's BioNTech position peaked at $346K in Q3 2023.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Corient Private Wealth's 13F filing for Q1 2025, filed 14 May 2025.